Lisa D. Coles

1.8k total citations
48 papers, 1.1k citations indexed

About

Lisa D. Coles is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Neurology. According to data from OpenAlex, Lisa D. Coles has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 19 papers in Pediatrics, Perinatology and Child Health and 13 papers in Neurology. Recurrent topics in Lisa D. Coles's work include Epilepsy research and treatment (18 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Drug Transport and Resistance Mechanisms (6 papers). Lisa D. Coles is often cited by papers focused on Epilepsy research and treatment (18 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Drug Transport and Resistance Mechanisms (6 papers). Lisa D. Coles collaborates with scholars based in United States, United Kingdom and Australia. Lisa D. Coles's co-authors include James C. Cloyd, Usha Mishra, Paul Tuite, Gülin Öz, Melissa Terpstra, Joan Fagg, Ivana Klimeš, Richard Mayou, Reena V. Kartha and Natalie D. Eddington and has published in prestigious journals such as The Journal of Physiology, Diabetes and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lisa D. Coles

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa D. Coles United States 17 287 248 219 197 162 48 1.1k
Frank Faltraco Germany 22 491 1.7× 174 0.7× 343 1.6× 93 0.5× 97 0.6× 41 1.6k
Masaya Tachibana Japan 25 291 1.0× 117 0.5× 449 2.1× 146 0.7× 143 0.9× 69 2.5k
Katsumi Imai Japan 26 685 2.4× 499 2.0× 432 2.0× 271 1.4× 132 0.8× 136 1.8k
Tae Suk Kim South Korea 21 147 0.5× 105 0.4× 248 1.1× 130 0.7× 38 0.2× 56 1.6k
Kanwaljit Singh United States 20 362 1.3× 136 0.5× 374 1.7× 87 0.4× 57 0.4× 50 1.3k
Xiaoping Yin China 18 115 0.4× 343 1.4× 380 1.7× 152 0.8× 208 1.3× 48 1.4k
Chiao‐Chicy Chen Taiwan 23 815 2.8× 83 0.3× 250 1.1× 180 0.9× 143 0.9× 45 1.9k
Joachim Pietz Germany 23 177 0.6× 543 2.2× 496 2.3× 70 0.4× 66 0.4× 44 1.5k
Lotfi Gaha Tunisia 18 492 1.7× 55 0.2× 180 0.8× 116 0.6× 67 0.4× 111 1.5k
Sumit Parikh United States 22 223 0.8× 161 0.6× 1.5k 6.7× 179 0.9× 120 0.7× 70 2.4k

Countries citing papers authored by Lisa D. Coles

Since Specialization
Citations

This map shows the geographic impact of Lisa D. Coles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa D. Coles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa D. Coles more than expected).

Fields of papers citing papers by Lisa D. Coles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa D. Coles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa D. Coles. The network helps show where Lisa D. Coles may publish in the future.

Co-authorship network of co-authors of Lisa D. Coles

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa D. Coles. A scholar is included among the top collaborators of Lisa D. Coles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa D. Coles. Lisa D. Coles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wang, Yongjun, Lisa D. Coles, Wenzhu Mowrey, et al.. (2024). Efficacy and tolerability of celastrol and edaravone in the multiple-hit rat model of infantile spasms. Epilepsy & Behavior. 162. 110159–110159. 1 indexed citations
4.
Casillas‐Espinosa, Pablo M., Wenzhu Mowrey, Qianyun Li, et al.. (2023). Tau Phosphorylation Patterns in the Rat Cerebral Cortex After Traumatic Brain Injury and Sodium Selenate Effects: An Epibios4rx Project 2 Study. Journal of Neurotrauma. 41(1-2). 222–243. 11 indexed citations
5.
Coles, Lisa D., Pablo M. Casillas‐Espinosa, Qianyun Li, et al.. (2023). Levetiracetam Pharmacokinetics and Brain Uptake in a Lateral Fluid Percussion Injury Rat Model. Journal of Pharmacology and Experimental Therapeutics. 386(2). 259–265. 5 indexed citations
6.
Seaquist, Elizabeth R., Anjali Kumar, Amir Moheet, et al.. (2023). Population Pharmacokinetic Model of N‐Acetylcysteine During Periods of Recurrent Hypoglycemia in Healthy Volunteers. Clinical Pharmacology in Drug Development. 12(12). 1234–1240. 2 indexed citations
9.
Mowrey, Wenzhu, Wei Liu, Qianyun Li, et al.. (2023). Early preclinical plasma protein biomarkers of brain trauma are influenced by early seizures and levetiracetam. Epilepsia Open. 8(2). 586–608. 8 indexed citations
10.
Zhu, Xiaohong, Paul Tuite, Lisa D. Coles, et al.. (2021). Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson’s Patients, Using In Vivo 31P MRS-Based Metabolic Imaging at 7T. Metabolites. 11(3). 145–145. 15 indexed citations
11.
Sathe, Abhishek G., Ellen Underwood, Lisa D. Coles, et al.. (2021). Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial. Epilepsia. 62(3). 795–806. 52 indexed citations
12.
Krach, Linda E., et al.. (2021). Characterizing Baclofen Withdrawal: A National Survey of Physician Experience. Pediatric Neurology. 122. 106–109. 4 indexed citations
13.
Patterson, Edward E., Chun‐Yi Wu, Dorota Żółkowska, et al.. (2021). Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs. Journal of Pharmacology and Experimental Therapeutics. 380(2). 104–113. 5 indexed citations
15.
Cock, Hannah R., Lisa D. Coles, Jordan Elm, et al.. (2019). Lessons from the Established Status Epilepticus Treatment Trial. Epilepsy & Behavior. 101(Pt B). 106296–106296. 11 indexed citations
16.
Coles, Lisa D., Ilo E. Leppik, Gregory A. Worrell, et al.. (2016). Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy. Frontiers in Veterinary Science. 3. 107–107. 10 indexed citations
17.
Krach, Linda E., Lisa D. Coles, Usha Mishra, et al.. (2016). A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics. PM&R. 9(8). 743–750. 12 indexed citations
18.
Zhou, Jie, Lisa D. Coles, Reena V. Kartha, et al.. (2015). Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status. Journal of Pharmaceutical Sciences. 104(8). 2619–2626. 38 indexed citations
19.
Coles, Lisa D., et al.. (2014). Pharmacokinetics and pharmacodynamics of intravenous baclofen in dogs: a preliminary study. Journal of Pharmacy and Pharmacology. 66(7). 935–942. 8 indexed citations
20.
Klimeš, Ivana, et al.. (1990). Psychological treatment for atypical non-cardiac chest pain: a controlled evaluation. Psychological Medicine. 20(3). 605–611. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026